REGENXBIO
RGNX
#7519
Rank
S$0.61 B
Marketcap
S$9.24
Share price
-0.28%
Change (1 day)
-40.07%
Change (1 year)

EPS for REGENXBIO (RGNX)

EPS in 2026 (TTM): S-$4.11

According to REGENXBIO's latest financial reports the company's current EPS (TTM) is S-$4.14. In 2025 the company made an earnings per share (EPS) of S-$4.85 an increase over its 2024 EPS that were of S-$5.95.

EPS history for REGENXBIO from 2015 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S-$4.11-15.18%
2025S-$4.85-18.44%
2024S-$5.95
2022S-$8.38-321.09%
2021S$3.79-198.33%
2020S-$3.8615.44%
2019S-$3.34-181.19%
2018S$4.12-229.15%
2017S-$3.193.35%
2016S-$3.085.42%
2015S-$2.92

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
S-$1.74-57.94%๐Ÿ‡บ๐Ÿ‡ธ USA